A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects

Clinical trial NCT06990776 · WITHDRAWN

Trial details

NCT number: NCT06990776
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2025-07-09
Primary completion: 2025-07-17
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.